author-photo

Sofie Daelemans

University of Antwerp

11

Papers

262

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (1)
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

2020 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

2019 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (168)
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases

2019 Angiogenesis
Show All
- Source
- Cite
- Save
Citations (43)
Histopathological growth patterns impact the efficacy of treatment for recurrent disease in patients with resected colorectal liver metastases

2019 Ejso
Show All
- Source
- Cite
- Save
Citations (0)
Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases

2018
Show All
- Source
- Cite
- Save
Citations (27)
The desmoplastic growth pattern predicts improved survival after resection of colorectal liver metastases

2018 Hpb
Show All
- Source
- Cite
- Save
Citations (0)
Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy

2018 Seminars in Cancer Biology
Show All
- Source
- Cite
- Save
Citations (23)